American Renal Associates Holdings, Inc. reported un-audited consolidated earnings results for the second quarter and six months ended June 30, 2017. For the quarter, the company reported net patient service operating revenues of $186.0 million, an increase of 0.2% as compared to $185.6 million for the prior-year period due to treatment growth and offset by adverse changes in payor mix. The company reported operating income of $27.2 million compared to $33.4 million, income before income taxes of $16.8 million compared to $11.9 million, net loss attributable to common shareholders of $4.6 million or $0.15 per diluted share compared to $21.6 million or $0.76 per diluted share, adjusted EBITDA-NCI of $27.4 million compared to $31.6 million, adjusted net income attributable to the company shareholders of $5.6 million or $0.16 per diluted share compared to $8.0 million or $0.25 per diluted share, cash provided by operating activities of $35.8 million compared to $52.7 million and purchases of property, equipment and intangible assets of $7.6 million compared to $17.8 million for the last year. Adjusted cash provided by operating activities less distributions to non-controlling interests was $17.1 million as compared to $32.3 million in the prior-year period. Capital expenditures was $7.6 million, of which $2 million was related to maintenance CapEx and the remainder was related to development CapEx.

Net patient service operating revenues for the six months ending June 30, 2017 were $363.0 million, an increase of 1.5% as compared to $357.7 million for the prior-year period. The company reported operating income of $39.6 million compared to $70.9 million, income before income taxes of $26.2 million compared to $37.1 million, net loss attributable to common shareholders of $17.0 million or $0.55 per diluted share compared to $17.8 million or $0.70 per diluted share, adjusted EBITDA-NCI of $48.8 million compared to $58.8 million, cash provided by operating activities of $52.4 million compared to $89.2 million and purchases of property, equipment and intangible assets of $14.1 million compared to $34.2 million for the last year. Adjusted cash provided by operating activities less distributions to Non-controlling interests were $14.5 million as compared to $47.5 million in the prior-year period.

The company is reiterating its prior guidance for the year 2017 adjusted EBITDA less NCI to be in a range of $100 million and $106 million.